QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 jmp-securities-reiterates-market-outperform-on-optimizerx-maintains-15-price-target

JMP Securities analyst Constantine Davides reiterates OptimizeRx (NASDAQ:OPRX) with a Market Outperform and maintains $15 pr...

 optimizerx-q4-adj-eps-026-inline-sales-2840m-beat-2647m-estimate

OptimizeRx (NASDAQ:OPRX) reported quarterly adjusted earnings of $0.26 per share which met the analyst consensus estimate. This...

 jmp-securities-initiates-coverage-on-optimizerx-with-market-outperform-rating-announces-price-target-of-15

JMP Securities analyst Constantine Davides initiates coverage on OptimizeRx (NASDAQ:OPRX) with a Market Outperform rating an...

 stifel-maintains-buy-on-optimizerx-maintains-13-price-target

Stifel analyst David Grossman maintains OptimizeRx (NASDAQ:OPRX) with a Buy and maintains $13 price target.

 rbc-capital-reiterates-outperform-on-optimizerx-maintains-17-price-target

RBC Capital analyst Sean Dodge reiterates OptimizeRx (NASDAQ:OPRX) with a Outperform and maintains $17 price target.

 earnings-scheduled-for-march-28-2024

Companies Reporting Before The Bell • Universal Stainless (NASDAQ:USAP) is expected to report quarterly earnings at $0.32 per ...

 optimizerx-earnings-preview
OptimizeRx Earnings Preview
03/27/2024 17:01:50

 optimizerx-reaffirms-prior-revenue-in-the-range-of-68m-70m-vs-6985m-est-and-adjusted-ebitda-estimates-for-fy2023

 OptimizeRx Corp. (the "Company") (NASDAQ:OPRX), the leading provider of healthcare technology solutions helping life s...

 rbc-capital-maintains-outperform-on-optimizerx-raises-price-target-to-17

RBC Capital analyst Sean Dodge maintains OptimizeRx (NASDAQ:OPRX) with a Outperform and raises the price target from $14 to ...

 barclays-initiates-coverage-on-optimizerx-with-equal-weight-rating-announces-price-target-of-15

Barclays analyst Stephanie Davis initiates coverage on OptimizeRx (NASDAQ:OPRX) with a Equal-Weight rating and announces Pri...

 earnings-scheduled-for-november-6-2023

Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is expected to report quarterly earnings at $0.16 per share on ...

 optimizerx-expects-fy23-revenues-to-be-between-68m-70m-vs-consensus-of-6051m-and-adjusted-ebitda-of-3m-4m

2023 Financial Outlook Based on OptimizeRx's results for the first nine months of 2023 and its recent acquisition, the Com...

 optimizerx-q3-adj-eps-009-up-from-007-yoy-sales-1633m-beat-1501m-estimate

OptimizeRx (NASDAQ:OPRX) reported quarterly adjusted earnings of $0.09 per share. This is a 28.57 percent increase over earning...

 digital-health-tech-optimizerxs-acquisition-of-medicx-health-to-boost-earnings-and-market-potential-analyst

OptimizeRx Corp (NASDAQ: OPRX) agreed to acquire Scottsdale, Arizona-based Healthy Offers Inc, dba Medicx Health, 

 why-inmode-shares-are-trading-lower-by-20-here-are-other-stocks-moving-in-thursdays-mid-day-session

Gainers

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION